Macrophage Plasticity in Cancer Therapy: Function, Timing, and Tradeoffs

Area of Science:

• Cancer Biology
• Immunology
• Therapeutic Development

Background:

• Tumor-associated macrophages (TAMs) are key targets in cancer therapy.
• Previous attempts to target TAMs have yielded inconsistent results due to their complex nature.

Purpose of the Study:

• To propose a framework for TAM-directed therapy that considers function and timing.
• To integrate evidence on stage-, sequence-, and context-dependent macrophage targeting.

Main Methods:

• Review and synthesis of existing research on TAM functions in solid tumors.
• Analysis of how TAM functions influence therapeutic choices (depletion, reprogramming, etc.).
• Consideration of therapeutic windows, biomarkers, and potential adverse effects.

Main Results:

• TAM phenotype and function are influenced by developmental origin, niche, metabolism, immune context, and treatment history.
• Recurrent TAM functions include vascular support, matrix remodeling, immune exclusion, tumor survival, antigen presentation, and tissue repair.
• Intervention effectiveness depends on lesion state and treatment sequence, with risks of toxicity and compensatory mechanisms.

Conclusions:

• TAM-directed therapy demands functional and temporal precision, dynamic reassessment, and attention to macrophage plasticity.
• Effective strategies must account for the dual role of TAM plasticity as both an opportunity and a risk.
• Personalized, context-aware approaches are crucial for successful TAM-targeted cancer treatment.